OVID

Ovid TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

OVID vs peer average

73/100

OVID vs. peer average (A vs. B)

Grade spread

A 3 · B 3 · C 3 · D 1 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

NVCT is the first available peer comparator.

Small-cap development-stage biotech with similar dependence on capital access and milestone execution rather than commercial revenue; indication and modality differ, but the financing/risk pattern is comparable.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerNVCTNuvectis

OVID

Ovid Therapeutics

NVCT

Nuvectis

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs NVCT

OVID / NVCT

Grade Position

Above peers

OVID vs. peer average (A vs. B)

73/100

Momentum

OVID

Value

OVID

Sentiment

OVID

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs OVID

60/100

80/100

20/100

Adlai Nortye Ltd ADR

80/100

CCCC

C4 Therapeutics Inc Common

60/100

NVCT is the first peer returned for this comparison set.